PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Valuation and Targets, page-357

  1. 316 Posts.
    lightbulb Created with Sketch. 37
    The presentation was very good and I feel extremely confident that we are heading in the right direction. Bear in mind the FDA could have given a negative response and it would have been all over
    Unfortunately the CR tarnished the great outcome in some people's minds
    better to have the money in the Bank with full steam ahead
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.